Exploring the Mesenchymal Stem Cell Secretome for Corneal Endothelial Proliferation
Ex vivo grown human corneal endothelial cells (HCEnC) are a new emerging treatment option to treat visually impaired patients aimed at alleviating the current global donor shortage. Expanding HCEnC is still challenging, and obtaining cells in sufficient quantities is a limiting factor. It is already...
Saved in:
Main Authors: | Bert Van den Bogerd, Nadia Zakaria, Steffi Matthyssen, Carina Koppen, Sorcha Ní Dhubhghaill |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/5891393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fish Scale-Derived Scaffolds for Culturing Human Corneal Endothelial Cells
by: Mohit Parekh, et al.
Published: (2018-01-01) -
Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies
by: Michel Haagdorens, et al.
Published: (2016-01-01) -
Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells
by: Witchayaporn Kamprom, et al.
Published: (2016-01-01) -
A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome
by: Clara Gallina, et al.
Published: (2015-01-01) -
Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
by: Kenji Tsuji, et al.
Published: (2018-01-01)